In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes

Aishwarya Ravindran, Marta Casal Moura, Fernando C. Fervenza, Samih H Nasr, Mariam P. Alexander, Mary E. Fidler, Loren P. Herrera Hernandez, Pingchuan Zhang, Joseph P. Grande, Lynn D Cornell, Lou Ann Gross, Vivian Negron, Grace E. Jenson, Benjamin J. Madden, M. Cristine Charlesworth, Sanjeev Sethi

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background In patients with secondary (autoimmune) membranous nephropathy, two novel proteins, Exostosin 1 and Exostosin 2 (EXT1/EXT2), are potential disease antigens, biomarkers, or both. In this study, we validate the EXT1/EXT2 findings in a large cohort of membranous lupus nephritis. Methods We conducted a retrospective cohort study of patients with membranous lupus nephritis, and performed immunohistochemistry studies on the kidney biopsy specimens against EXT1 and EXT2. Clinicopathologic features and outcomes of EXT1/EXT2-positive versus EXT1/EXT2-negative patients were compared. Results Our study cohort included 374 biopsy-proven membranous lupus nephritis cases, of which 122 (32.6%) were EXT1/EXT2-positive and 252 (67.4%) were EXT1/EXT2-negative. EXT1/EXT2-positive patients were significantly younger (P50.01), had significantly lower serum creatinine levels (P50.02), were significantly more likely to present with proteinuria $3.5 g/24 h (P50.009), and had significantly less chronicity features (glomerulosclerosis, P50.001 or interstitial fibrosis and tubular atrophy, P,0.001) on kidney biopsy. Clinical follow-up data were available for 160 patients, of which 64 (40%) biopsy results were EXT1/EXT2-positive and 96 (60%) were EXT1/EXT2-negative. The proportion of patients with class 3/4 lupus nephritis coexisting with membranous lupus nephritis was not different between the EXT1/EXT2-positive and EXT1/ EXT2-negative groups (25.0% versus 32.3%; P50.32). The patients who were EXT1/EXT2-negative evolved to ESKD faster and more frequently compared with EXT1/EXT2-positive patients (18.8% versus 3.1%; P50.003). Conclusions The prevalence of EXT1/EXT2 positivity was 32.6% in our cohort of membranous lupus nephritis. Compared with EXT1/EXT2-negative membranous lupus nephritis, EXT1/EXT2-positive disease appears to represent a subgroup with favorable kidney biopsy findings with respect to chronicity indices. Cases of membranous lupus nephritis that are EXT1/EXT2-negative are more likely to progress to ESKD compared with those that are EXT1/EXT2-positive.

Original languageEnglish (US)
Pages (from-to)695-706
Number of pages12
JournalJournal of the American Society of Nephrology
Issue number3
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes'. Together they form a unique fingerprint.

Cite this